Xando Díaz-Villamarín

ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Venues

Pharmaceutics

Genes

Fundación Pública Andaluza para la investigación Biosanitaria Andalucía Oriental

Universidad de Granada (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Fundación Pública Andaluza para la investigación Biosanitaria Andalucía Oriental Aug 01 2016

Spain

Researcher - Ubiquitous Pharmacogenomics project (U-PGx)

Education History

Universidad de Granada

Spain

PHD

Publications

Xando Díaz-Villamarín, María Martínez-Pérez, María Teresa Nieto-Sánchez, Gabriela Ruiz-Tueros, Emilio Fernández-Varón, Alicia Torres-García, Beatriz González Astorga, Isabel Blancas, Antonio J Iáñez, José Cabeza-Barrera, Rocío Morón
Novel Genetic Variants Explaining Severe Adverse Drug Events after Clinical Implementation of DPYD Genotype-Guided Therapy with Fluoropyrimidines: An Observational Study. Pharmaceutics 16 (7) (2024)
Xando Díaz-Villamarín, María Martínez-Pérez, María Teresa Nieto-Sánchez, Gabriela Ruiz-Tueros, Emilio Fernández-Varón, Alicia Torres-García, Beatriz González Astorga, Isabel Blancas, Antonio J Iáñez, José Cabeza-Barrera, Rocío Morón
Novel Genetic Variants Explaining Severe Adverse Drug Events after Clinical Implementation of DPYD Genotype-Guided Therapy with Fluoropyrimidines: An Observational Study. Pharmaceutics 16 (7) (2024)
Xando Díaz-Villamarín, María Martínez-Pérez, María Teresa Nieto-Sánchez, Gabriela Ruiz-Tueros, Emilio Fernández-Varón, Alicia Torres-García, Beatriz González Astorga, Isabel Blancas, Antonio J Iáñez, José Cabeza-Barrera, Rocío Morón
Novel Genetic Variants Explaining Severe Adverse Drug Events after Clinical Implementation of DPYD Genotype-Guided Therapy with Fluoropyrimidines: An Observational Study. Pharmaceutics 16 (7) (2024)
David Blánquez-Martínez, Xando Díaz-Villamarín, Sonia García-Rodríguez, Alba Antúnez-Rodríguez, Ana Pozo-Agundo, Luis Javier Martinez-Gonzalez, José Ignacio Muñoz-Ávila, Cristina Lucía Dávila-Fajardo
Genetic Polymorphisms in VEGFR Coding Genes ( FLT1 / KDR ) on Ranibizumab Response in High Myopia and Choroidal Neovascularization Patients. Pharmaceutics 14 (8) (2022)
David Blánquez-Martínez, Xando Díaz-Villamarín, Alba Antúnez-Rodríguez, Ana Pozo-Agundo, José Ignacio Muñoz-Ávila, Luis Javier Martinez-Gonzalez, Cristina Lucía Dávila-Fajardo
Genetic Polymorphisms Affecting Ranibizumab Response in High Myopia Patients. Pharmaceutics 13 (11) (2021)
Xando Díaz-Villamarín, David Blánquez-Martínez, Ana Pozo-Agundo, Ana María Pérez-Gutiérrez, José Ignacio Muñoz-Ávila, Alba Antúnez-Rodríguez, Ana Estefanía Fernández-Gómez, Paloma García-Navas, Luis Javier Martinez-Gonzalez, Cristina Lucía Dávila-Fajardo
Genetic Variants Affecting Anti-VEGF Drug Response in Polypoidal Choroidal Vasculopathy Patients: A Systematic Review and Meta-Analysis. Genes 11 (11) (2020)

Xando Díaz-Villamarín.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Xando Díaz-Villamarín